These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 23089746

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Anidulafungin Susceptibility Testing of Candida glabrata Isolates from Blood Cultures by the MALDI Biotyper Antibiotic (Antifungal) Susceptibility Test Rapid Assay.
    Vatanshenassan M, Arastehfar A, Boekhout T, Berman J, Lass-Flörl C, Sparbier K, Kostrzewa M.
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285227
    [Abstract] [Full Text] [Related]

  • 23. Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair Pathway.
    Singh A, Healey KR, Yadav P, Upadhyaya G, Sachdeva N, Sarma S, Kumar A, Tarai B, Perlin DS, Chowdhary A.
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610199
    [Abstract] [Full Text] [Related]

  • 24. Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.
    Pham CD, Iqbal N, Bolden CB, Kuykendall RJ, Harrison LH, Farley MM, Schaffner W, Beldavs ZG, Chiller TM, Park BJ, Cleveland AA, Lockhart SR.
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4690-6. PubMed ID: 24890592
    [Abstract] [Full Text] [Related]

  • 25. The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Murine Model of Candida glabrata Colonization and Systemic Dissemination.
    Healey KR, Nagasaki Y, Zimmerman M, Kordalewska M, Park S, Zhao Y, Perlin DS.
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971865
    [Abstract] [Full Text] [Related]

  • 26. Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.
    Marcos-Zambrano LJ, Gómez-Perosanz M, Escribano P, Zaragoza O, Bouza E, Guinea J.
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3579-86. PubMed ID: 27021323
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M, Deshpande LM, Davis AP, Rhomberg PR, Pfaller MA.
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
    [Abstract] [Full Text] [Related]

  • 29. Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).
    Kritikos A, Neofytos D, Khanna N, Schreiber PW, Boggian K, Bille J, Schrenzel J, Mühlethaler K, Zbinden R, Bruderer T, Goldenberger D, Pfyffer G, Conen A, Van Delden C, Zimmerli S, Sanglard D, Bachmann D, Marchetti O, Lamoth F, Fungal Infection Network of Switzerland (FUNGINOS).
    Clin Microbiol Infect; 2018 Nov; 24(11):1214.e1-1214.e4. PubMed ID: 29909005
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Improved detection of Candida sp. fks hot spot mutants by using the method of the CLSI M27-A3 document with the addition of bovine serum albumin.
    Garcia-Effron G, Park S, Perlin DS.
    Antimicrob Agents Chemother; 2011 May; 55(5):2245-55. PubMed ID: 21383097
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.
    Cleary JD, Garcia-Effron G, Chapman SW, Perlin DS.
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2263-5. PubMed ID: 18378714
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden.
    Axner-Elings M, Botero-Kleiven S, Jensen RH, Arendrup MC.
    J Clin Microbiol; 2011 Jul; 49(7):2516-21. PubMed ID: 21543574
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.
    Desnos-Ollivier M, Bretagne S, Raoux D, Hoinard D, Dromer F, Dannaoui E, European Committee on Antibiotic Susceptibility Testing.
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3092-8. PubMed ID: 18591282
    [Abstract] [Full Text] [Related]

  • 39. Rezafungin In Vitro Activity against Contemporary Nordic Clinical Candida Isolates and Candida auris Determined by the EUCAST Reference Method.
    Helleberg M, Jørgensen KM, Hare RK, Datcu R, Chowdhary A, Arendrup MC.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 32015032
    [Abstract] [Full Text] [Related]

  • 40. In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata Isolates.
    Bordallo-Cardona MÁ, Escribano P, de la Pedrosa EG, Marcos-Zambrano LJ, Cantón R, Bouza E, Guinea J.
    Antimicrob Agents Chemother; 2017 Feb 24; 61(2):. PubMed ID: 27872063
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.